<p>Peter Nara of Biological Mimetics, Inc. in the U.S. will use a new vaccine technology to produce non-infectious poliovirus-like particles that can be used in one highly effective, low-cost polio vaccine capable of inducing protective immunity against all circulating serotypes.</p>


Peter Nara of Biological Mimetics, Inc. in the U.S. will use a new vaccine technology to produce non-infectious poliovirus-like particles that can be used in one highly effective, low-cost polio vaccine capable of inducing protective immunity against all circulating serotypes.